A metabolic basis for fibromyalgia and its related disorders: the possible role of resistance to thyroid hormone

被引:39
作者
Garrison, RL
Breeding, PC
机构
[1] Apt. D70, Lexington, KY 40502
关键词
D O I
10.1016/S0306-9877(02)00294-3
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
It has long been recognized that the symptom complex of fibromyalgia can be seen with hypothyroidism. Hypothyroidism may been categorized, like diabetes, into type I (hormone deficient) and type II (hormone resistant). Most cases of fibromyalgia fall into the latter category. The syndrome is reversible with treatment, and is usually of late onset. It is likely more often acquired than due to mutated receptors. Now that there is evidence to support the hypothesis that fibromyalgia may be due to thyroid hormone resistance, four major questions appear addressable. First, can a simple biomarker be found to help diagnose it? Second, what other syndromes similar to Fibromyalgia may share a thyroid-resistant nature? Third, in non-genetic cases, how is resistance acquired? Fourth, what other methods of treatment become available through this new understanding? Preliminary evidence suggests that serum hyaluronic acid is a simple, inexpensive, sensitive, and specific test that identifies fibromyalgia. Overlapping symptom complexes suggest that chronic fatigue syndrome, Gulf war syndrome, premenstrual syndrome, post traumatic stress disorder, breast implant silicone sensitivity syndrome, bipolar affective disorder, systemic candidiasis, myofascial pain syndrome, and idiopathic environmental intolerance are similar enough to fibromyalgia to merit investigation for possible thyroid resistance. Acquired resistance may be due most often to a recently recognized chronic consumptive coagulopathy, which itself may be most often associated with chronic infections with mycoplasmids and related microbes or parasites. Other precipitants of thyroid resistance may use this or other paths as well. In addition to experimentally proven treatment with supraphysiologic doses of thyroid hormone, the thyroid-resistant disorders might be treatable with anti-hypercoagulant, anti-infective, insulin-sensitizing, and hyaluronolytic strategies. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:182 / 189
页数:8
相关论文
共 59 条
[1]
Albright F, 1942, ENDOCRINOLOGY, V30, P922
[2]
Basal temperature versus basal metabolism [J].
Barnes, B .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1942, 119 :1072-1074
[3]
Barnes B., 1976, HYPOTHYROIDISM UNSUS
[4]
BARTALENA L, 1994, ACTA MED AUST, V21, P60
[5]
Mycoplasmas: Sophisticated, reemerging, and burdened by their notoriety [J].
Baseman, JB ;
Tully, JG .
EMERGING INFECTIOUS DISEASES, 1997, 3 (01) :21-32
[6]
SYMPTOMS OF RAYNAUDS SYNDROME IN PATIENTS WITH FIBROMYALGIA - A STUDY UTILIZING THE NIELSEN TEST, DIGITAL PHOTOPLETHYSMOGRAPHY, AND MEASUREMENTS OF PLATELET ALPHA-2-ADRENERGIC RECEPTORS [J].
BENNETT, RM ;
CLARK, SR ;
CAMPBELL, SM ;
INGRAM, SB ;
BURKHARDT, CS ;
NELSON, DL ;
PORTER, JM .
ARTHRITIS AND RHEUMATISM, 1991, 34 (03) :264-269
[7]
LOW-LEVELS OF SOMATOMEDIN C IN PATIENTS WITH THE FIBROMYALGIA SYNDROME - A POSSIBLE LINK BETWEEN SLEEP AND MUSCLE PAIN [J].
BENNETT, RM ;
CLARK, SR ;
CAMPBELL, SM ;
BURCKHARDT, CS .
ARTHRITIS AND RHEUMATISM, 1992, 35 (10) :1113-1116
[8]
BERG D, 1999, BLOOD COAGUL FIBRIN, V10, P1
[9]
BICK RL, 1985, DISORDERS HOMEOSTASI, P165
[10]
RHEUMATIC SYNDROMES OF MYXEDEMA [J].
BLAND, JH ;
FRYMOYER, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1970, 282 (21) :1171-&